UPM has signed EUR 1 250 million revolving credit facility agreement

UPM has signed a €1.25 billion syndicated multi‑currency revolving credit facility with a five‑year maturity and two one‑year extension options, refinancing its prior €750m (March 2020) and €1,000m (December 2023) RCFs and available for general corporate purposes. The facility was successfully syndicated with 15 banks — led by coordinating bookrunners Crédit Agricole CIB, Danske Bank and Nordea, alongside BBVA, Bank of China, BNP Paribas, Citibank, Commerzbank, DBS, DNB, J.P. Morgan, OP Corporate Bank, SEB, Swedbank and UniCredit — a vote of confidence that extends UPM’s liquidity runway, lengthens tenor and reduces near‑term refinancing risk.

Analysis

UPM has signed a €1,250 million syndicated multi-currency revolving credit facility with a five-year maturity and two one-year extension options subject to lenders' approval. The new committed facility refinances UPM's existing €750 million RCF dated March 2020 and €1,000 million RCF dated December 2023 and is available for general corporate purposes. Fifteen banks participated in the syndication, led by Crédit Agricole CIB, Danske Bank and Nordea with a broad group of global bookrunners including BBVA, Bank of China, BNP Paribas, Citibank, Commerzbank, DBS, DNB, J.P. Morgan, OP Corporate Bank, SEB, Swedbank and UniCredit.

The syndication and five-year tenor constitute a vote of confidence in UPM’s credit quality and extend its liquidity runway while reducing immediate refinancing risk, aligning with the mildly positive market sentiment signal. Notably, the new facility (€1,250m) is €500m smaller than the combined prior facilities (€1,750m), which represents a real reduction in committed backstop liquidity that could matter if cash flows weaken. The release highlights UPM’s scale—approximately €10.3 billion in annual sales and ~15,800 employees—and third-party sustainability recognitions, factors that likely supported lender participation.

Key residual risks are the lender approval requirement for extension options and the lack of disclosed covenant and pricing detail in the announcement; these items will determine how materially the facility improves credit metrics. Investors should monitor forthcoming disclosures on covenant headroom, actual drawings versus undrawn commitments, and quarterly cash flow/net debt trends to assess whether the smaller committed amount materially tightens liquidity or is offset by operational cash generation.

Key Decisions for Investors

• Treat the transaction as mildly credit-positive and consider maintaining or modestly increasing exposure to UPM given the five-year tenor and broad bank backing, provided portfolio credit limits permit
• Monitor the reduction in committed capacity (new €1,250m vs prior combined €1,750m) as a potential liquidity constraint and watch upcoming cash flow, net debt and covenant disclosures before making sizeable position changes
• Be prepared to hedge or reduce exposure if lenders decline one-year extension options or if disclosed covenants/pricing tighten materially, and reassess after UPM publishes usage and covenant headroom details